The effects of HDACs on cell growth and survival were predominantly studied in BRAFV600E melanoma models, but also other BRAF-altered cancers, such as colon cancer and thyroid cancer, revealed HDAC-dependent mechanisms of cell death. Here, HDAC9 is linked to cancer.